PureTech Health PLC at Jefferies London Healthcare Conference Transcript
All right. Welcome. My name is Peter Welford. I'm the European biotech and pharma analyst at Jefferies in London; I don't know how many times I've said that today.
It's my pleasure to introduce the next company in this track, which is PureTech. We're going to have few words, first of all, from Daphne Zohar, the CEO. She is going to introduce the company to you, and then we'll go into Q&A. (Conference Instructions)
But with that, over to you, Daphne. Thank you very much.
Great. Thank you. Thanks, Peter, and thanks to Jefferies for hosting us today and welcome to all of you that are joining us in person and via webcast.
We will be making some forward-looking statements today. So I encourage you to go to sec.gov for a full list of all of the risks and potential disclosures. All of the information that we're talking about is relevant as of today, and we do not undertake to update that information
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |